Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of Leukocyte Biology
|
September 14, 2000
Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
J L Lathey, D Brambilla, M M Goodenow, et al.
British Journal of Haematology
|
June 20, 2024
The clinical spectrum of HbSC sickle cell disease-not a benign condition
M Nelson, L Noisette, N Pugh, et al.
Vox Sanguinis
|
December 22, 2016
Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm
N H Roubinian, J E Hendrickson, D J Triulzi, et al.
Journal of Clinical Microbiology
|
September 1, 1996
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group
W A Scott, D Brambilla, E Siwak, et al.
Journal of Clinical Microbiology
|
November 1, 1996
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories
B Yen-Lieberman, D Brambilla, B Jackson, et al.
AIDS (London, England)
|
November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program
D Brambilla, P S Reichelderfer, J W Bremer, et al.
Journal of Clinical Microbiology
|
February 12, 1998
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons
D Brambilla, S Leung, J Lew, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2000
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates
M L Landry, S Stanat, K Biron, et al.
Controlled Clinical Trials
|
March 11, 1998
Stroke prevention trial in sickle cell anemia
R J Adams, V C McKie, D Brambilla, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of Leukocyte Biology
|
September 14, 2000
Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
J L Lathey, D Brambilla, M M Goodenow, et al.
British Journal of Haematology
|
June 20, 2024
The clinical spectrum of HbSC sickle cell disease-not a benign condition
M Nelson, L Noisette, N Pugh, et al.
Vox Sanguinis
|
December 22, 2016
Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm
N H Roubinian, J E Hendrickson, D J Triulzi, et al.
Journal of Clinical Microbiology
|
September 1, 1996
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group
W A Scott, D Brambilla, E Siwak, et al.
Journal of Clinical Microbiology
|
November 1, 1996
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories
B Yen-Lieberman, D Brambilla, B Jackson, et al.
AIDS (London, England)
|
November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program
D Brambilla, P S Reichelderfer, J W Bremer, et al.
Journal of Clinical Microbiology
|
February 12, 1998
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons
D Brambilla, S Leung, J Lew, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2000
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates
M L Landry, S Stanat, K Biron, et al.
Controlled Clinical Trials
|
March 11, 1998
Stroke prevention trial in sickle cell anemia
R J Adams, V C McKie, D Brambilla, et al.
Page
of 5